Octopus Future Generations Vct Plc investment portfolio

CellVoyant Technologies Ltd offers AI‑driven platforms for cell‑based therapeutic development, including FateView—a cloud‑based predictive cell analytics tool that uses label‑free microscopy and machine‑learning to forecast cell states—and FateDrive, an AI‑guided optimisation service that models and simulates process conditions to improve yield, quality and reproducibility for biotechnology and pharmaceutical companies.

CoMind Technologies Limited develops non‑invasive brain‑computer interface and neurotechnology platforms that monitor brain activity for clinical healthcare and other industry applications. Its products aim to improve patient outcomes by providing brain‑health monitoring without invasive procedures.